Single-Cell Multi-Omics Market is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025

The single-cell multi-omics market has been evolving mainly due to the technological advancements taking place in clinical research, especially in the oncology segment. Although a growing market, the consistent evolution of technology within the market to intensify initiatives undertaken to ease diagnosis and treatment initiation have greatly adhered the market to high dynamicity. Rapid technological developments and their simultaneous adoption among major companies have made the single-cell multi-omics one of the most lucrative markets within the precision diagnostic biosphere. With both established as well as emerging players, disruptive companies playing a highly significant role in the market, this industry is rapidly evolving to regularize single-cell multi-omics in clinical as well as non-clinical applications.

The single-cell multi-omics market is estimated at $1,221.5 million in 2020 and is expected to grow at a CAGR of 21.16% during the forecast period, 2020-2025.Factors responsible for the growth of the market include increasing number of large-scale genomics studies leveraging single-cell RNA sequencing (sc-RNA), increasing adoption of personalized medicine for the screening and diagnostics of genetic disorders, and increasing disposable income in emerging economies.

Applications for which single-cell multi-omics can be used include clinical research, translational research, and synthetic biology.End-user industries for single-cell multi-omics market include academic and research institutions, biopharmaceutical and biotechnological companies, contract research organizations, and other end users.Some of the key companies operating in the market include NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, 10x Genomics, Inc., Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation.

Growth Drivers

• Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)

• Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders

• Increasing Disposable Income in Emerging Economies

Market Restraints

• High Cost of Single-Cell Analysis and Integration of Data

• Limited Availability of Large Online Data Storage and Analysis Platforms

Market Opportunities

• Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations

• Requirement for the Development of Advanced Solutions Based on Single-Cell Technology

• Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan

• Expansion into New Research Application such as Single-Cell Metabolomics

Within the research report, the market is segmented on the basis of product type, sample type, omics type, technique, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Request a Sample- https://bisresearch.com/requestsample?id=1061&type=download

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog